Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers
We investigated here the response of anti-SARS-CoV-2 IgA antibodies to BNT162b2 primary vaccination followed by administration of a homologous booster dose in baseline seronegative healthcare workers.
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2022-05-01
|
| Series: | Advances in Laboratory Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/almed-2022-0033 |
| _version_ | 1797795066740211712 |
|---|---|
| author | Salvagno Gian Luca Henry Brandon M. Pighi Laura De Nitto Simone Lippi Giuseppe |
| author_facet | Salvagno Gian Luca Henry Brandon M. Pighi Laura De Nitto Simone Lippi Giuseppe |
| author_sort | Salvagno Gian Luca |
| collection | DOAJ |
| description | We investigated here the response of anti-SARS-CoV-2 IgA antibodies to BNT162b2 primary vaccination followed by administration of a homologous booster dose in baseline seronegative healthcare workers. |
| first_indexed | 2024-03-13T03:12:14Z |
| format | Article |
| id | doaj.art-ca76f03b75dd4c1ba43c52e9122535ff |
| institution | Directory Open Access Journal |
| issn | 2628-491X |
| language | English |
| last_indexed | 2024-03-13T03:12:14Z |
| publishDate | 2022-05-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Advances in Laboratory Medicine |
| spelling | doaj.art-ca76f03b75dd4c1ba43c52e9122535ff2023-06-26T10:46:04ZengDe GruyterAdvances in Laboratory Medicine2628-491X2022-05-013216717010.1515/almed-2022-0033Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workersSalvagno Gian Luca0Henry Brandon M.1Pighi Laura2De Nitto Simone3Lippi Giuseppe4Section of Clinical Biochemistry, University of Verona, Verona, ItalyClinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USASection of Clinical Biochemistry, University of Verona, Verona, ItalySection of Clinical Biochemistry, University of Verona, Verona, ItalySection of Clinical Biochemistry, University of Verona, Verona, ItalyWe investigated here the response of anti-SARS-CoV-2 IgA antibodies to BNT162b2 primary vaccination followed by administration of a homologous booster dose in baseline seronegative healthcare workers.https://doi.org/10.1515/almed-2022-0033antibodiescovid-19igasars-cov-2vaccination |
| spellingShingle | Salvagno Gian Luca Henry Brandon M. Pighi Laura De Nitto Simone Lippi Giuseppe Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers Advances in Laboratory Medicine antibodies covid-19 iga sars-cov-2 vaccination |
| title | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers |
| title_full | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers |
| title_fullStr | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers |
| title_full_unstemmed | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers |
| title_short | Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers |
| title_sort | impact of bnt162b2 primary vaccination and homologous booster on anti sars cov 2 iga antibodies in baseline seronegative healthcare workers |
| topic | antibodies covid-19 iga sars-cov-2 vaccination |
| url | https://doi.org/10.1515/almed-2022-0033 |
| work_keys_str_mv | AT salvagnogianluca impactofbnt162b2primaryvaccinationandhomologousboosteronantisarscov2igaantibodiesinbaselineseronegativehealthcareworkers AT henrybrandonm impactofbnt162b2primaryvaccinationandhomologousboosteronantisarscov2igaantibodiesinbaselineseronegativehealthcareworkers AT pighilaura impactofbnt162b2primaryvaccinationandhomologousboosteronantisarscov2igaantibodiesinbaselineseronegativehealthcareworkers AT denittosimone impactofbnt162b2primaryvaccinationandhomologousboosteronantisarscov2igaantibodiesinbaselineseronegativehealthcareworkers AT lippigiuseppe impactofbnt162b2primaryvaccinationandhomologousboosteronantisarscov2igaantibodiesinbaselineseronegativehealthcareworkers |